Tag: vaccines

Does the Flu Vaccine Prevent Death?

Dear Editor,

My letter is concerned with a topic of utmost importance: The effect of the flu vaccine on flu-related death. That’s the ultimate endpoint of interest for vaccine effectiveness (VE) research, yet it is not captured in most studies that employ the test-negative design.

Faksova et al. (January 2026) reported in your journal results from a large cohort study of the flu vaccine in 2024–2025 in elderly residents (age≥65) of three Nordic countries. The estimated VE against flu-related death was 63%, which corresponds to a risk ratio (RR) of 0.37. How robust is the result? What does sensitivity analysis show?

The authors relied on a matched design to avoid confounding bias, a major threat in observational research. Unvaccinated members of the cohort were matched to the vaccinated (one-to-one matching) on several variables, including key comorbidities.

Sweden was not included in the mortality analysis (small numbers), and the mortality graphs were displayed by country (Denmark, Finland). I will examine the data from Denmark, a matched cohort of over one million people.

Graphs of cumulative mortality by vaccination status were displayed as of 14 days after a matched index date. For a vaccinated person, the index date was the vaccination date; for their unvaccinated counterpart, that matched date was just a random date on the calendar. I will return to this point later when we discuss their health status.

Keep reading

Learn lessons from covid: do not take the mRNA flu “vaccines”

The FDA’s approval of Moderna’s mFLUSIVA marks another major expansion of modified mRNA technology. Approved on 5 August for adults aged 50 and older in the United States, the product is intended for use during the 2026–2027 influenza season and is expected to appear on shelves in the coming weeks.

This deserves immediate attention. Despite all of the harms we witnessed during the covid-19 “vaccine” rollout, the same dangerous technological platform is now being introduced into routine seasonal influenza inoculation. The United States may be first, but applications are also being considered elsewhere, making this an international issue. Please warn everyone of the dangers and do not take these injections.

From Covid to Seasonal Influenza

The covid-19 injections represented a dramatic departure from traditional vaccine technology. Rather than introducing an antigen directly, the mRNA products deliver tens of trillions of copies of foreign genetic code inside PEGylated lipid nanoparticles, intended to cause the recipient’s own cells to manufacture foreign proteins.

Many of us raised concerns about this technology before the covid-19 injection rollout began. Those concerns included the distribution of infinitely penetrating lipid nanoparticles throughout the body, the hyper-persistence of the modified mRNA, the continued production of foreign proteins and the high risk of serious adverse effects.

The safety signals reported following the covid-19 “vaccine” rollout only intensified those concerns. Before the covid-19 injections, there were typically only a few hundred deaths reported each year following vaccination in the United States. This is not accounting for underreporting. After the modified mRNA covid-19 injections were rolled out, this rose to tens of thousands of reported deaths within months, with higher numbers in those initial months than for all other vaccines, for all other diseases, over the previous 30 years combined. Not to mention, data shows the covid injections have a negative efficacy; they increase the risk of covid infection. They produced only harm, no benefit.

Keep reading

FDA Approves 3 New COVID-19 Vaccines

The Food and Drug Administration on Aug. 27 approved COVID-19 vaccines from Pfizer, Moderna, and Sanofi.

The new shots from Pfizer and Moderna use the messenger ribonucleic acid (mRNA) platform and target the XFG strain, a subvariant of the JN.1 variant.

Regulators also cleared a COVID-19 vaccine shot from Sanofi that targets the XFG strain and does not use mRNA technology.

The approval is for people aged 65 and older, as well as people aged 12 to 64 who have one or more underlying conditions such as obesity that officials say puts them at higher risk of severe COVID-19.

Regulators have been approving updated COVID-19 vaccines for several years, in a bid to better match circulating strains. The previous versions of the vaccines were estimated to provide 58 percent protection against hospitalization, according to the Centers for Disease Control and Prevention.

The FDA did not announce the approvals in a press release, as it has done in the past.

The FDA and its parent agency, the Department of Health and Human Services, did not respond to requests for comment by publication time.

Health Secretary Robert F. Kennedy Jr. has been critical of mRNA vaccines against respiratory diseases, saying they don’t work well.

Manufacturers are going to run single-arm studies evaluating the shots in humans, according to FDA documents. The companies were going to be made to run placebo-controlled trials, but officials released them from that requirement “because of operational and feasibility challenges,” the documents said.

FDA officials in 2025 said that new placebo-controlled trials were imperative to determine how well the COVID-19 vaccines actually performed, given it has been years since such trials were conducted. Pfizer and Moderna committed to running placebo-controlled trials, as did Novavax, which has since licensed its COVID-19 vaccine to Sanofi.

Keep reading

Trump Admin Hands Bill Gates’ GAVI Vaccine Syndicate $600 Million

The U.S. Department of State and U.S. Department of Health and Human Services last month revealed they “will immediately release all $600 million in Congressionally appropriated funds” for Gavi, the Vaccine Alliance, Bill Gates’ international vaccine syndicate, according to a State Department press release.

In June 2025, HHS Secretary Robert F. Kennedy Jr. had withdrawn American funding from Gavi, citing child deaths linked to the vaccines the organization dispenses worldwide.

But one year later, Secretary of ​State Marco Rubio promised that the United States would “re-engage” with Gavi, citing a purported Ebola outbreak as justification.

The new State Department press release emphasizes President Donald Trump gave the directive himself.

Per the release:

“Last year, President Trump directed Secretary of Health and Human Services Robert F. Kennedy, Jr. and Secretary of State Marco Rubio to engage directly with Gavi, the Vaccine Alliance (Gavi), and secure meaningful reforms before the United States would consider future support. Those discussions resulted in significant commitments that strengthen vaccine safety, improve public health, and better align Gavi’s work with the principles of Gold Standard Science and transparency. Based on those commitments, the United States will immediately release all $600 million in Congressionally appropriated funds to Gavi for both FY25 and FY26.”

The agreement included “reducing reliance on mercury-containing vaccines, where suitable alternatives are available.”

The release didn’t specify which alternatives would be used nor cite any relevant safety studies.

But it did confirm vaccine manufacturers would benefit:

“Achieving these transitions will require manufacturers to expand production capacity, countries to adopt newer vaccine formulations, and Gavi’s governing Board to complete the necessary approvals. The United States recognizes these implementation challenges but welcomes Gavi’s commitment to work toward these goals through transparent governance and responsible stewardship.”

The Trump admin ultimately wants to “resume its place on the Gavi Board”:

“In addition, given the sizeable contribution the United States is making to improve access to vaccines, the United States expects to resume its place on the Gavi Board. In this role, the United States will continue to hold Gavi accountable for measurable progress toward these commitments. It will evaluate any future U.S. support based on demonstrated performance, accountability, and implementation of these reforms.”

Keep reading

New Zealand: Deaths up, fertility down; is this the legacy of covid “vaccines”?

The births and deaths figures for the year ended June 2026 have just been released by StatsNZ. Compared to the previous year: 

  • Births were down 3.6% 
  • Deaths were up 1.9% 
  • Fertility per woman was down 3.8% 
  • Infant mortality was up by 2.7%, although this last statistic was inflated to some extent by late registrations. 

The rate of deaths per thousand population had been declining since a peak of 7.59 in 2022, falling to 7.02 in 2025. The 2026 figures reversed this trend with a rise to 7.10. This compares to the 2015 – 2019 average of 6.84, meaning that deaths are currently running at 3.8% above pre-pandemic levels. This equates to an additional 1,411 deaths in the year to June 2026, which would not have been expected if pre-pandemic trends had continued.

The New Zealand (“NZ”) fertility rate has been declining every year since 2008 and is now at a historic low. The 2026 figures are 28% below levels necessary to maintain a population. Despite this, the NZ population is continuing to grow as a result of net immigration.

The most concerning figure in the latest data is therefore the upward movement in the rate of mortality. This increase in levels of excess mortality is very concerning. Although the 2026 rise does not yet amount to a trend, it should be a red flag. It points to a drop in the underlying level of immunity which is affecting the whole population.

In this light, it remains disturbing that Health NZ are not closely investigating the possible causes. A comparison of health outcomes of the covid-vaccinated with the unvaccinated is long overdue. Studies published overseas which we have covered have pointed to differences in rates of cancer and cardiac problems, for example. These have disproportionately affected younger age groups.

RCR has produced a comprehensive report showing that 311,257 NZ teens were exposed to an elevated risk of myocarditis from covid injections despite the government having been warned of this risk before rolling out vaccination for this age group. We have previously reported high levels of chest pain presentations for under 40s at emergency departments. Prior to the pandemic, it was recognised in the literature that there is a five-year elevated risk of complications following a myocarditis diagnosis. Five years have now passed since these injections. Health NZ should be following up and producing a very detailed picture of cardiac health outcomes as a precautionary measure. 

A great many published studies have focused on investigating an immune deficit following covid vaccination. Since the year-to-June figures were compiled, more evidence of a health deficit in NZ has emerged. You must have read about the depth of the current flu and winter illness seasonal health crisis. Hospitals are overwhelmed as never before.

On 15 August the NZ Herald reported ‘Middlemore Hospital hits ‘terrifying’ record as paramedics treat patients in corridors’. In one 24-hour period nearly 500 patients presented to the emergency department at Middlemore, beating the previous record of 280. 

According to Stuff newspaper, the St John ambulance service activated its major incident response and emergency operations centre after a week of sustained exceptional demand culminated in its busiest day on record.

This week Stuff headlined ‘Flu wards set up, elective surgery cancelled as hospital admissions surge’. The NZ Herald reported high rates of student absences due to sickness and parents unable to cope at home. The Royal New Zealand College of General Practitioners has asked practices nationwide to reinstate some covid-era infection controls, including phone-first triage and separating patients with respiratory symptoms.

Without a detailed investigation of the causes of the higher levels of sickness among the general population broken down by age, vaccination status and disease type, it is not possible for Health NZ to understand and respond appropriately to the current health crisis. A task force should be set up to undertake this analysis as a precautionary priority and make their findings public. This will inform and potentially reassure the public by determining how much of this effect is due to covid infection and how much to vaccination or other factors.

Keep reading

RFK Jr. Fact Checks Democratic Governor Who Claimed ‘There Is No Fetal Tissue’ in MMR Vaccine

Health and Human Services Secretary Robert F. Kennedy Jr. fact-checked Pennsylvania Democratic Gov. Josh Shapiro after he claimed that there is “no fetal tissue” in the measles, mumps, and rubella vaccine, known as MMR.

During a Tuesday news conference, Shapiro accused Kennedy of spreading vaccine misinformation and tied it to the deaths of two people in Lancaster County, which he said were “measles-associated,” a claim county officials have since disputed.

In a phone call with Kennedy, the governor recounted, “I was very, very blunt with him and I made very clear that his actions and the rhetoric that’s coming from this administration are having a negative impact on communities across America, particularly right here in Pennsylvania.”

“There’s real life consequences to spreading misinformation. There are real-life consequences to scaring people and not relying on actual doctors and actual medical professionals to provide unbiased information to parents so that we can make reasonable decisions for our kids,” he added.

“Sharing conspiracy theories and misinformation does not help the cause of public health,” Shapiro said.

Kennedy responded with a post on X, writing, “At his press conference today, Pennsylvania Governor Josh Shapiro accused me of promoting conspiracy theories because I told him, during an earlier telephone conversation, that some Americans had religious objections to the MMR vaccine because it contained fetal tissue. ‘There is no fetal tissue in the MMR,’ he told me.”

The post included video testimony from Dr. Stanley Plotkin, who developed the rubella component of the MMR vaccine, according to the Smithsonian.

“Plotkin admits to butchering 76 aborted normally developing fetuses, all over three months old, in just one of the many studies that led to the development of his vaccine,” RFK Jr. wrote.

“The rubella virus used in MMR-II is grown on the cultured cell line composed of lung tissue from an aborted three-month-old female embryo and listed as ‘WI-38 human diploid lung fibroblasts’ in the ingredients of MMR-II as portions of these cells end up in each vial of MMR II,” Kennedy added.

Keep reading

Dr. Stanley Plotkin, the World’s Leading Vaccinologist, Under Oath

For those who don’t know, Dr. Stanley Plotkin is the world’s leading vaccinologist, whom I’ve had the opportunity to depose. Here are a few clips of Dr. Plotkin answering questions about vaccines and autism, aborted fetal tissue used in vaccine development, and health outcomes among vaccinated and unvaccinated children:

Who is Stanley Plotkin

Vaccines and Autism

Clinical Trials of Hep B Vaccine

Vaccinated vs. Unvaccinated Study

Full 9-hour Deposition

Keep reading

CDC V-Safe Data Reveals 185,285 People Reported Long-Term Health Problems After COVID-19 “Vaccination”

A new study analyzing data from the CDC’s V-safe surveillance system has identified 185,285 people who reported that their health remained worse three months or longer after COVID-19 vaccination and who attributed that deterioration to the vaccine.

The findings come from an analysis by MIT researchers Retsef Levi and Nelson Lu of one of the largest active COVID-19 vaccine surveillance datasets ever assembled.

V-safe enrolled more than 10 million COVID-19 vaccine recipients and repeatedly contacted participants after vaccination to ask about symptoms, daily functioning, healthcare utilization, and changes in their health. Unlike VAERS, which relies primarily on spontaneous adverse-event reports, V-safe actively prompted enrolled vaccine recipients to provide follow-up information over time, including at 3, 6, and 12 months.

Among 9,904,924 V-safe enrollees aged 16 or older included in the analysis, 185,285 (1.87%) reported prolonged worsening of their health that they believed was related to COVID-19 vaccination. Women reported the problem at an even higher rate: 137,430 of 6,141,800 women, or 2.24%.

Keep reading

Cancer “vaccines”: Don’t let them inject you unless you fully understand what they are injecting

After five years of being bashed on unsafe, ineffective, uncontrollable spike protein-producing (Spikevax, mNEXSPIKE) vaccines, Moderna is solidly back home in the cancer business, and their stock performance couldn’t be any better.

The mRNA Cancer Long Game: Moderna’s Pivot from Pandemic to Personalised Chemotherapy

There’s a narrative that’s taken hold in the financial press and biotechnology cheerleading circles: Moderna, having saved humanity from covid, is now developing “cancer vaccines” that will do for oncology what Operation Warp Speed did for respiratory viruses.

This is marketing, not medicine.

What Moderna is actually doing is using synthetic messenger RNA as a delivery mechanism for personalised neoantigens as a part of toxic combination chemotherapy. Calling these “vaccines” is a linguistic sleight of hand designed to borrow the halo from childhood immunisation while obscuring the reality of what’s being injected into patients’ bodies week after week.

The remainder of this article is behind a paywall.  Click HERE to subscribe to Focal Points and read the full article.  After subscribing, you can claim one free-to-read article.

[Note from The Exposé: A cancer “vaccine” programme is also underway in the UK, with clinical trials currently taking place. “The NHS Cancer Vaccine Launch Pad (CVLP) is a platform that will speed up access to messenger ribonucleic acid (mRNA) personalised cancer vaccine and other immunotherapy clinical trials for people who have been diagnosed with cancer. It will also accelerate the development of cancer vaccines and other immunotherapies as a form of cancer treatment,” NHS England says.]

Keep reading

Former CDC Scientist Whose Studies Were Used to ‘Debunk’ Vaccine-Autism Link Will Plead Guilty

A former Centers for Disease Control and Prevention (CDC) scientist who played a crucial role in research rebutting any link between vaccines and autism is expected to plead guilty next week to wire fraud and money laundering.

Poul Thorsen, 65, is finalizing a plea deal with prosecutors relating to charges stemming from a 2011 federal indictment, Nathan Kitchens, assistant U.S. Attorney for the Northern District of Georgia, told The Defender.

Thorsen, who began working for the CDC in the late 1990s, faces two counts of wire fraud and nine counts of money laundering related to over $1 million in CDC grant money. The funds were earmarked for autism and public health research, but Thorsen allegedly used them to buy a home, two cars and a motorcycle.

Kitchens declined to comment on whether Thorsen will plead guilty to all or some of the charges.

Thorsen has been held in federal custody without bail since his extradition from Germany to the U.S. in May. The case is being heard at a federal court in Georgia, where the CDC is headquartered.

Researcher James Grundvig, the parent of a child with autism who was vaccine-injured, called the expected guilty plea “a very big deal.”

Grundvig, who wrote “Master Manipulator: The Explosive True Story of Fraud, Embezzlement, and Government Betrayal at the CDC,” which focused on the Thorsen case, praised U.S. Health Secretary Robert F. Kennedy Jr. for extraditing Thorsen “in record speed.”

He said Thorsen likely understands that the FBI and U.S. Department of Justice have “all the goods” to prosecute him.

“I guess Thorsen’s realizing, since he’s in American jail already and has no chance for bail, he might as well make a plea deal,” Grundvig said.

Keep reading